December 17, 2014 8:47 PM ET

Professional Services

Company Overview of H. Lee Moffitt Cancer Center & Research Institute

Company Overview

H. Lee Moffitt Cancer Center & Research Institute is a not for-profit institution that focuses on prevention and cure of cancer. The institution offers private patient rooms, blood and marrow transplant programs, outpatient treatment programs, patient care, research, and education services. Additionally, it publishes Today's Tomorrows, a community newsletter about cancer care, research, and education. H. Lee Moffitt was founded in 1986 and is based in Tampa, Florida.

10441 University Center Drive

Tampa, FL 33612

United States

Founded in 1986

Phone:

888-663-3488

Key Executives for H. Lee Moffitt Cancer Center & Research Institute

Chief Executive Officer and Center Director
Age: 64
Executive Vice President Applied Science
Vice President of Public Relations and Marketing
Compensation as of Fiscal Year 2014.

H. Lee Moffitt Cancer Center & Research Institute Key Developments

Moffitt Cancer Center Names Jennifer Greenman to Vice President and Chief Information Officer

Jennifer Greenman has been named Vice President and Chief Information Officer at Moffitt Cancer Center. She will report to Mark Hulse, R.N., Moffitt's Chief Administration Officer. In her new role, Greenman will provide leadership and strategic direction for technology initiatives that support Moffitt's mission to contribute to the prevention and cure of cancer. Greenman has been with Moffitt since July 2013. She previously served as the cancer center's Senior Director for Application Services.

Lion Biotechnologies Announces Exclusive License Agreement with Moffitt Cancer Center

Lion Biotechnologies, Inc. announced that it has entered into an exclusive, worldwide license agreement with Moffitt Cancer Center. Under the terms of the agreement, Lion has licensed from Moffitt the rights to develop and commercialize new technologies to enhance TIL production from melanoma, which may be applicable to other tumor types that historically have not produced therapeutic TILs. The license is based on two provisional patent applications, filed under Compositions and Methods for Improving Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy.

Similar Private Companies By Industry

Company Name Region
Dnv Petroleum Service Inc. United States
Green Peak Partners United States
Fairfield Testing Laboratories, LLC United States
Brown Armstrong Accountancy Corporation United States
Jaffe Freedman & Hait United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact H. Lee Moffitt Cancer Center & Research Institute, please visit www.moffitt.usf.edu. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.